A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Clinical trial NCT03850067 · COMPLETED
Trial details
- NCT number
- NCT03850067
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2024-07-16
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.